The global Cancer Biopsy Market, valued at USD 28.12 billion in 2023, is anticipated to experience substantial growth, with projections estimating it will reach USD 85.03 billion by 2032. The market is expected to grow at a compound annual growth rate (CAGR) of 13.0% over the forecast period from 2024 to 2032. This surge in market value is driven by the increasing prevalence of cancer...